John P Marinelli1, Zane Schnurman2, Daniel E Killeen3, Ashley M Nassiri1, Jacob B Hunter3, Katherine A Lees4, Christine M Lohse5, J Thomas Roland6, John G Golfinos2, Douglas Kondziolka2, Michael J Link1,7, Matthew L Carlson1,7. 1. Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA. 2. Department of Neurosurgery, NYU Langone Medical Center, New York, New York, USA. 3. Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 4. Department of Otolaryngology-Head and Neck Surgery, University of Texas Medical Branch, Galveston, Texas, USA. 5. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. 6. Department of Otolaryngology-Head and Neck Surgery, NYU Langone Health, New York, New York, USA. 7. Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Abstract
BACKGROUND: The current study aims to characterize the natural history of sporadic vestibular schwannoma volumetric tumor growth, including long-term growth patterns following initial detection of growth. METHODS: Volumetric tumor measurements from 3505 serial MRI studies were analyzed from unselected consecutive patients undergoing wait-and-scan management at three tertiary referral centers between 1998 and 2018. Volumetric tumor growth was defined as a change in volume ≥20%. RESULTS: Among 952 patients undergoing observation, 622 experienced tumor growth with initial growth-free survival rates (95% CI) at 1, 3, and 5 years following diagnosis of 66% (63-69), 30% (27-34), and 20% (17-24). Among 405 patients who continued to be observed despite demonstrating initial growth, 210 experienced subsequent tumor growth with subsequent growth-free survival rates at 1, 3, and 5 years following initial growth of 77% (72-81), 37% (31-43), and 24% (18-31). Larger tumor volume at initial growth (HR 1.13, P = .02) and increasing tumor growth rate (HR 1.31; P < .001) were significantly associated with an increased likelihood of subsequent growth, whereas a longer duration of time between diagnosis and detection of initial growth was protective (HR 0.69; P < .001). CONCLUSIONS: While most vestibular schwannomas exhibit an overall propensity for volumetric growth following diagnosis, prior tumor growth does not perfectly predict future growth. Tumors can subsequently grow faster, slower, or demonstrate quiescence and stability. Larger tumor size and increasing tumor growth rate portend a higher likelihood of continued growth. These findings can inform timing of intervention: whether upfront at initial diagnosis, after detection of initial growth, or only after continued growth is observed.
BACKGROUND: The current study aims to characterize the natural history of sporadic vestibular schwannoma volumetric tumor growth, including long-term growth patterns following initial detection of growth. METHODS: Volumetric tumor measurements from 3505 serial MRI studies were analyzed from unselected consecutive patients undergoing wait-and-scan management at three tertiary referral centers between 1998 and 2018. Volumetric tumor growth was defined as a change in volume ≥20%. RESULTS: Among 952 patients undergoing observation, 622 experienced tumor growth with initial growth-free survival rates (95% CI) at 1, 3, and 5 years following diagnosis of 66% (63-69), 30% (27-34), and 20% (17-24). Among 405 patients who continued to be observed despite demonstrating initial growth, 210 experienced subsequent tumor growth with subsequent growth-free survival rates at 1, 3, and 5 years following initial growth of 77% (72-81), 37% (31-43), and 24% (18-31). Larger tumor volume at initial growth (HR 1.13, P = .02) and increasing tumor growth rate (HR 1.31; P < .001) were significantly associated with an increased likelihood of subsequent growth, whereas a longer duration of time between diagnosis and detection of initial growth was protective (HR 0.69; P < .001). CONCLUSIONS: While most vestibular schwannomas exhibit an overall propensity for volumetric growth following diagnosis, prior tumor growth does not perfectly predict future growth. Tumors can subsequently grow faster, slower, or demonstrate quiescence and stability. Larger tumor size and increasing tumor growth rate portend a higher likelihood of continued growth. These findings can inform timing of intervention: whether upfront at initial diagnosis, after detection of initial growth, or only after continued growth is observed.
Authors: Robert J Macielak; Viengneesee Thao; Bijan J Borah; James P Moriarty; John P Marinelli; Jamie J Van Gompel; Matthew L Carlson Journal: Otol Neurotol Date: 2021-07-16 Impact factor: 2.311
Authors: John P Marinelli; Katherine A Lees; Christine M Lohse; Colin L W Driscoll; Brian A Neff; Michael J Link; Jamie J Van Gompel; Matthew L Carlson Journal: Otol Neurotol Date: 2020-10 Impact factor: 2.311
Authors: Gian Gaetano Ferri; Giovanni Carlo Modugno; Antonio Pirodda; Antonio Fioravanti; Fabio Calbucci; Alberto Rinaldi Ceroni Journal: Laryngoscope Date: 2008-06 Impact factor: 3.325
Authors: John P Marinelli; Matthew L Carlson; Jacob B Hunter; Ashley M Nassiri; David S Haynes; Michael J Link; Christine M Lohse; Martin Reznitsky; Sven-Eric Stangerup; Per Caye-Thomasen Journal: Otol Neurotol Date: 2021-09-01 Impact factor: 2.311